Pharmicell Co Ltd

005690

Company Profile

  • Business description

    Pharmicell Co Ltd is a biotechnology company that engages in the manufacturing of biopharmaceutical medicines in South Korea. The firm operates two business divisions: the Biomedical Division and the Biochemical Division. The firm derives key revenue from the Biochemical Division. The Biomedical Division focuses on the development of stem cell therapies as its core business. The Biochemical Division produces and sells electronic materials with excellent electrical properties (low dielectric constant, low dielectric loss), pharmaceutical intermediates such as nucleosides and mPEG, eco-friendly phosphorus-based flame retardants (for textiles and electronic materials), and other industrial fine chemical products.

  • Contact

    874 Eonju-ro, Gangnam-gu
    7th Floor, Ssangbong Building
    Sinsa-dong
    Seoul135-010
    KOR

    T: +82 234960114

    http://www.pharmicell.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    161

Stocks News & Analysis

stocks

Cheap ASX share may have more room to run

Shares are cheap despite rebounding share price, yet risks remain.
stocks

ASX listed media giant drives strong earnings growth

Digital growth drives earnings beat for media share.
stocks

ASX real estate platform outperforms yet questions remain

Valuation remains a key concern despite strong August reporting.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,412.6024.80-0.26%
CAC 408,714.9315.220.17%
DAX 4026,319.45179.320.69%
Dow JONES (US)54,036.93151.830.28%
FTSE 10010,901.0933.200.31%
HKSE25,881.84213.810.83%
NASDAQ26,690.62342.261.30%
Nikkei 22566,931.481,324.772.02%
NZX 50 Index13,845.7021.570.16%
S&P 5007,757.6447.680.62%
S&P/ASX 2009,220.8028.80-0.31%
SSE Composite Index3,948.648.600.22%

Market Movers